Skip to main content

Advertisement

Log in

Clinico-pathological Study of Limb Salvage Surgery for Osteosarcoma: Experience in a Rural Cancer Center

  • Original Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Although recent multimodality therapeutic protocols have led to improved survival in osteosarcoma (OS), the outcome still remains dismal. Ongoing international multicentric trials on OS aim to randomize patients for optimum management, based on histological response to NACT. The pathologic response to neoadjuvant chemotherapy (NACT) is the most important factor predicting prognosis. In this study of 23 cases of limb salvage surgery post neoadjuvant chemotherapy, mean age was 18.3 years, with male predominance. 65.5 % cases were conventional OS. Histologic assessment of chemotherapeutic effect done by Huvos grading revealed good response (Huvos lll and lV) in 15 (65.2 %) and poor response (Huvos l and ll) in eight (34.8 %). A scoring based on MRI with a scale of 1–6 was compared with histologic response. Five (62.5 %) of poor responders showed score of >3 and 73.3 % of good responders showed ≤3. Dose intensity of NACT was calculated and correlated with the histological response. 53.3 % of good responders showed ARDI > 0.9. Five (21.7 %) developed local recurrence and 10(43.4 %) had pulmonary metastasis. Adoption of more aggressive treatment modalities may ensure better histologic response and longer event free survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Bacci G, Briccoli A, Rocca M (2003) Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide. Ann Oncol 14(7):1126–1134

    Article  CAS  PubMed  Google Scholar 

  2. Bacci G, Longhi A, Versari M (2006) Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy15-year experience in 789 patients treated at a single institution. Cancer 106:1154–1161

    Article  PubMed  Google Scholar 

  3. Bajpai J, Gamnagatti S, Kumar R (2011) Role of MRI in osteosarcoma for evaluation and prediction of chemotherapy response: correlation with histological necrosis. Pediatr Radiol 41(4):441–450

    Article  PubMed  Google Scholar 

  4. Carrle D, Bielack SS (2006) Current strategies of chemotherapy in osteosarcoma. International Orthopaedics (SICOT) 30:445–451

    Article  Google Scholar 

  5. Chen Y, Yang Y, Yuan Z (2012) Predicting chemosensitivity in osteosarcoma prior to chemotherapy: an investigational study of biomarkers with immunohistochemistry. Oncol lett 3(5):1011–1016

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Coffin CM, Lowichik A, Zhou H (2005) Treatment effects in pediatric soft tissue and bone tumors. Practical considerations for the pathologist. Am J Clin Pathol 123:75–90

    Article  PubMed  Google Scholar 

  7. Davis AM, Bell RS, Goodwin PJ (1994) Prognostic factors in osteosarcoma: a critical review. J Clin Oncol 12(2):423–431

    Article  CAS  PubMed  Google Scholar 

  8. DeVita VT, Lawrence TS, Rosenberg SA (2008) Hellman & Rosenberg's cancer: principles & practice of oncology, 8th edn. Lippincott Williams & Wilkins

  9. DiCaprio MR, Friedlaender GE (2003) Malignant bone tumors: limb sparing versus amputation. J Am Acad Orthop Surg 11(1):25–37

    Article  PubMed  Google Scholar 

  10. Fletcher CDM, Unni KK (2002) Mertens F: World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. IARC Press, Lyon

    Google Scholar 

  11. Foote MA (1998) The importance of planned dose of chemotherapy on time: do we need to change our clinical practice? Oncologist 3(5):365–368

    CAS  PubMed  Google Scholar 

  12. Geller GS, Gorlick R (2010) Osteosarcoma: a review of diagnosis, management, and treatment strategies. Clin Adv Hematol Oncol 8(10):705–718

    PubMed  Google Scholar 

  13. Goorin AM, Schwartzentruber DJ, Devidas M Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol 21:1574–1580

  14. Hendershot E, Pappo A, Malkin D (2006) Tumor necrosis in pediatric osteosarcoma: impact of modern therapies. J Pediatr Oncol Nurs 23:176–181

    Article  PubMed  Google Scholar 

  15. Hong S, Shin SJ, Jung M, Jeong J, Lee YJ, Shin K-H, Roh JK, Rha SY (2011) Comparison of long- term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremity. Oncology 80:107–117

    Article  CAS  PubMed  Google Scholar 

  16. Huvos A (1991) Bone tumors: diagnosis, treatment, and prognosis, 2nd edn. Saunders, Philadelphia, PA

    Google Scholar 

  17. Huvos AG, Rosen G, Marcove RC (1977) Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med 101:14–18

    CAS  PubMed  Google Scholar 

  18. Khan SA, Poudel RR, Kumar VS. Evaluation and comparison of factors associated with local recurrence in operated cases of osteosarcomas- a retrospective study. ISOLS

  19. Lewis IJ, Weeden S, Machin D (2000) Received dose and dose-intensity of chemotherapy and outcome in nonmetastatic extremity osteosarcoma. European osteosarcoma intergroup. J Clin Oncol 18(24):4028–4037

    Article  CAS  PubMed  Google Scholar 

  20. Li X, Moretti VM, Ashana AO (2012) Impact of close surgical margin on local recurrence and survival in osteosarcoma. International Orthopaedics (SICOT) 36:131–137

    Article  Google Scholar 

  21. Mangham DC, Athanasou NA (2011) Guidelines for histopathological specimen examination and diagnostic reporting of primary bone tumours. Clinical Sarcoma Res 1(1):6

    Article  Google Scholar 

  22. Miwa S, Takeuchi A, Ikeda H, Shirai T, Yamamoto N, et al. Prognostic value of histological response to chemotherapy in osteosarcoma patients receiving tumor-bearing frozen autograft. PLoS One 8(8):e71362. doi:10.1371/journal.pone.0071362

  23. Raymond AK, Jaffe N (2009) Osteosarcoma multidisciplinary approach to the management from the pathologist’s perspective. In: Pediatric and adolescent osteosarcoma. Springer, New York

    Google Scholar 

  24. Raymond AK, Chawla SP, Carrasco CH, et al. (1987) Osteosarcoma chemotherapy effect: a prognostic factor. Semin Diagn Pathol 4:212–236

    CAS  PubMed  Google Scholar 

  25. Saeter G (2003) ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of osteosarcoma. Ann Oncol 14(8):1165–1166

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We acknowledge the invaluable help of the teaching and technical staff of department of Pathology, Malabar Cancer Centre and dedicate this article to the young patients suffering from osteosarcoma on whom this article is based.

Conflict of Interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Divya Vijayanarasimha.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vijayanarasimha, D., Nayanar, S.K., Vikram, S. et al. Clinico-pathological Study of Limb Salvage Surgery for Osteosarcoma: Experience in a Rural Cancer Center. Indian J Surg Oncol 8, 136–141 (2017). https://doi.org/10.1007/s13193-016-0547-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-016-0547-8

Keywords

Navigation